FCAG
GMED icon

First Capital Advisors Group’s Globus Medical GMED Stock Holding History

First Capital Advisors Group’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$595 Buy
+10
New +$570 ﹤0.01% 909

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

First Capital Advisors Group's GMED Position: Q2 2023 in Review

First Capital Advisors Group opened a new position in Globus Medical (GMED) in Q2 2023: 10 shares worth $595. The stake represents ﹤0.01% of the portfolio and ranks #909 among its holdings.

382 funds tracked by Wall St. Rank hold GMED as of Q2 2023.

  • First Capital Advisors Group held 10 shares of Globus Medical worth $595 as of Q2 2023.
  • Globus Medical was a new First Capital Advisors Group position in Q2 2023.
  • Globus Medical made up ﹤0.01% of First Capital Advisors Group's portfolio in Q2 2023, its #909 holding.
  • 382 funds tracked by Wall St. Rank held Globus Medical as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.